Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy

被引:4
|
作者
Lepre, Caterina Claudia [1 ]
Russo, Marina [2 ]
Trotta, Maria Consiglia [2 ]
Petrillo, Francesco [3 ]
D'Agostino, Fabiana Anna [4 ]
Gaudino, Gennaro [5 ]
D'Amico, Giovanbattista [6 ]
Campitiello, Maria Rosaria [7 ,8 ]
Crisci, Erminia [4 ]
Nicoletti, Maddalena [4 ]
Gesualdo, Carlo [4 ]
Simonelli, Francesca [4 ]
D'Amico, Michele [2 ]
Hermenean, Anca [1 ]
Rossi, Settimio [4 ]
机构
[1] Vasile Goldis Western Univ Arad, Aurel Ardelean Inst Life Sci, Arad 310144, Romania
[2] Univ Campania Luigi Vanvitelli, Dept Expt Med, I-80138 Naples, Italy
[3] Univ Campania Luigi Vanvitelli, Dept Expt Med, Course Translat Med, I-80138 Naples, Italy
[4] Univ Campania Luigi Vanvitelli, Multidisciplinary Dept Med, Surg & Dent Sci, I-80138 Naples, Italy
[5] Univ Foggia, Sch Anesthesia & Intens Care, I-71122 Foggia, Italy
[6] Univ Studies Aquila, Sch Geriatr, I-67010 Laquila, Italy
[7] ASL Salerno, Dept Obstet & Gynecol, I-84124 Salerno, Italy
[8] ASL Salerno, Dept Physiopathol Human Reprod, I-84124 Salerno, Italy
关键词
diabetic retinopathy; neuroinflammation; ROS; ER stress; NLRP3; inflammasome; galectins; P2X7R; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; MOUSE MODEL; P2X(7) RECEPTOR; RETINAL MICROGLIA; EPITHELIAL-CELLS; MACULAR EDEMA; MULLER CELLS; ACTIVATION; NLRP3;
D O I
10.3390/ijms24119721
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic retinopathy (DR) is the most frequent microvascular retinal complication of diabetic patients, contributing to loss of vision. Recently, retinal neuroinflammation and neurodegeneration have emerged as key players in DR progression, and therefore, this review examines the neuroinflammatory molecular basis of DR. We focus on four important aspects of retinal neuroinflammation: (i) the exacerbation of endoplasmic reticulum (ER) stress; (ii) the activation of the NLRP3 inflammasome; (iii) the role of galectins; and (iv) the activation of purinergic 2X7 receptor (P2X7R). Moreover, this review proposes the selective inhibition of galectins and the P2X7R as a potential pharmacological approach to prevent the progression of DR.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] The role of the purinergic receptor p2x7 in the pathogenesis of atherosclerosis
    Merz, J.
    Heidenreich, A.
    Stachon, P.
    Bode, C.
    Zirlik, A.
    EUROPEAN HEART JOURNAL, 2017, 38 : 853 - 853
  • [22] The P2X7 receptor as a therapeutic target
    Romagnoli, Romeo
    Baraldi, Pier Giovanni
    Cruz-Lopez, Olga
    Lopez-Cara, Carlota
    Preti, Delia
    Borea, Pier Andrea
    Gessi, Stefania
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (05) : 647 - 661
  • [23] P2X7 Receptor as a Therapeutic Target
    De Marchi, Elena
    Orioli, Elisa
    Dal Ben, Diego
    Adinolfi, Elena
    ION CHANNELS AS THERAPEUTIC TARGETS, PT B, 2016, 104 : 39 - 79
  • [24] Role of Purinergic P2X7 Receptors in Allergic Inflammation.
    Faffe, D. S.
    Costa-Vieira, J.
    Mazzoli-Rocha, F.
    Cagido, V. R.
    Moncao-Ribeiro, L. C.
    Takiya, C. M.
    Coutinho-Silva, R.
    Zin, W. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [25] Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists
    El Idrissi, Imane Ghafir
    Podlewska, Sabina
    Abate, Carmen
    Bojarski, Andrzej J.
    Lacivita, Enza
    Leopoldo, Marcello
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (11) : 1361 - 1403
  • [26] Role of P2X7 receptors in the development of diabetic retinopathy
    Sugiyama, Tetsuya
    WORLD JOURNAL OF DIABETES, 2014, 5 (02): : 141 - 145
  • [27] Interaction of Purinergic P2X4 and P2X7 Receptor Subunits
    Markwardt, Fritz
    Schneider, Markus
    Prudic, Kirsten
    Pippel, Anja
    Klapperstueck, Manuela
    Mueller, Christa
    Stolz, Michaela
    Schumacher, Michaela
    Schmalzing, Gunther
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 421A - 421A
  • [28] Interaction of Purinergic P2X4 and P2X7 Receptor Subunits
    Schneider, Markus
    Prudic, Kirsten
    Pippel, Anja
    Klapperstueck, Manuela
    Braam, Ursula
    Mueller, Christa E.
    Schmalzing, Guenther
    Markwardt, Fritz
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [29] The purinergic P2X7 ion channel receptor - a 'repair' receptor in bone
    Jorgensen, Niklas Rye
    CURRENT OPINION IN IMMUNOLOGY, 2018, 52 : 32 - 38
  • [30] The P2X7 purinergic receptor as a molecular target in bipolar disorder
    Gubert, Carolina
    Fries, Gabriel Rodrigo
    de Aguiar, Bianca Wollenhaupt
    Rosa, Adriane Ribeiro
    Busnello, Joao Vicente
    Ribeiro, Luciana
    Morrone, Fernanda Bueno
    Oliveira Battastini, Ana Maria
    Kapczinski, Flavio
    NEUROPSYCHIATRIA I NEUROPSYCHOLOGIA, 2013, 8 (01): : 1 - 7